Epitomics
Latest round
- Series C
Last raised
- Apr 2004
Total raised
- $14M
Investors
- 3
About Epitomics
Epitomics, Inc.Epitomics, Inc. specializes in the development of monoclonal antibodies and was founded in 2002 in Burlingame, US. It was acquired by Abcam plc in March 2012 for USD 155 mn. The company has engaged in three deals since its inception, with the most recent deal date being March 5, 2012.Epitomics offers a range of high-quality antibodies, proteins, and reagents tailored to the life sciences research community. Its product line includes more than 37,000 recombinant antibodies utilized in various applications such as Western blotting and immunohistochemistry.Epitomics generates revenue through direct sales to research institutions, academic laboratories, and biotech firms. The company's sales model enables researchers to purchase products and assay kits, enhancing accessibility to necessary research tools.Following its acquisition by Abcam plc, Epitomics is positioned to leverage its capabilities for future growth. The integration into Abcam is expected to support the launch of new products, although specific release dates have not been detailed. The company intends to expand its market presence, particularly in North America, Europe, and Asia-Pacific, to meet the demands of academic and commercial researchers. The USD 155 mn from the Trade Sale in March 2012 is anticipated to bolster these initiatives, facilitating product development and market expansion.
Who invested in Epitomics
3 investors across 2 rounds
See all investors in Epitomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epitomics
Who invested in Epitomics?
Epitomics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epitomics raised?
Epitomics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Epitomics last raise money?
Epitomics's most recent round on record is a Series C, in Apr 2004.
What does Epitomics do?
Epitomics is a biotechnology company.
Where is Epitomics headquartered?
Epitomics is headquartered in Burlingame, US.
Which VCs invest in companies like Epitomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Epitomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Epitomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.